SG144944A1 - Stable modifications of tegaserod hydrogen maleate - Google Patents

Stable modifications of tegaserod hydrogen maleate

Info

Publication number: SG144944A1
Authority: SG; Singapore
Prior art keywords: hydrogen maleate; stable modifications; tegaserod hydrogen; tegaserod; stable
Prior art date: 2003-07-24

Application number

SG200805476-9A

Other languages

English (en)

Inventor

Sabine Pfeffer

Christian Vitzling

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-24

Filing date

2004-07-23

Publication date

2008-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG144944(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-07-23 Application filed by Novartis Ag filed Critical Novartis Ag

2008-08-28 Publication of SG144944A1 publication Critical patent/SG144944A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Glass Compositions (AREA)
Liquid Crystal Substances (AREA)

SG200805476-9A 2003-07-24 2004-07-23 Stable modifications of tegaserod hydrogen maleate SG144944A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US48963803P	2003-07-24	2003-07-24

Publications (1)

Publication Number	Publication Date
SG144944A1 true SG144944A1 (en)	2008-08-28

Family

ID=34135099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200805476-9A SG144944A1 (en)	2003-07-24	2004-07-23	Stable modifications of tegaserod hydrogen maleate

Country Status (24)

Country	Link
US (1)	US20070112056A1 (is)
EP (2)	EP1651601A1 (is)
JP (1)	JP2006528609A (is)
KR (1)	KR20060040710A (is)
CN (1)	CN1826318A (is)
AR (1)	AR045081A1 (is)
AU (1)	AU2004263285A1 (is)
BR (1)	BRPI0412830A (is)
CA (1)	CA2532351A1 (is)
CO (1)	CO5680418A2 (is)
EC (1)	ECSP066306A (is)
IL (1)	IL172914A0 (is)
IS (1)	IS8321A (is)
MA (1)	MA27935A1 (is)
MX (1)	MXPA06000917A (is)
MY (1)	MY137386A (is)
NO (1)	NO20060915L (is)
NZ (1)	NZ544596A (is)
PE (1)	PE20050253A1 (is)
RU (1)	RU2349585C2 (is)
SG (1)	SG144944A1 (is)
TN (1)	TNSN06024A1 (is)
TW (1)	TW200510302A (is)
WO (1)	WO2005014544A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1723106A2 (en) *	2004-10-19	2006-11-22	Teva Pharmaceutical Industries Ltd.	Purification of tegaserod maleate
RU2007132704A (ru) *	2005-01-31	2009-03-10	Новартис АГ (CH)	Органические соединения
CZ298399B6 (cs) *	2005-05-02	2007-09-19	Zentiva, A. S.	Zpusob prípravy 2-[(5-methoxy-1 H-indol-3-yl) methylen]-N-pentylkarbazimidamidu (tegaserodu)
MX2007002113A (es) *	2005-06-22	2007-04-27	Teva Pharma	Formas polimorfas de maleato de tegaserod.
WO2007119109A2 (en) *	2005-10-06	2007-10-25	Medichem, S.A.	Processes for preparing tegaserod maleate and pharmaceutical compositions containing it
GB0524668D0 (en) *	2005-12-02	2006-01-11	Novartis Ag	Organic compounds
WO2007120924A1 (en) *	2006-04-17	2007-10-25	Teva Pharmaceutical Industries Ltd.	Preparation of tegaserod maleate free of iodide
EP1956002A1 (en) *	2007-02-07	2008-08-13	Chemo Ibérica, S.A.	New tegaserod maleate polymorphs and process for their preparation
EP2146958A1 (en) *	2007-05-17	2010-01-27	Generics Ýuk¨Limited	Process for the preparation of form a of tegaserod

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01242588A (ja) *	1988-03-25	1989-09-27	Chiba Gosei Kenkyusho:Kk	７―シアノメチルチオアセトアミド―７α―メトキシ―３―（１―メチル―１Ｈ―テトラゾール―５―イル）チオメチル―３―セフェム―４―カルボン酸の結晶及びその製造方法
HUT64023A (en) *	1991-03-22	1993-11-29	Sandoz Ag	Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
GB9106179D0 (en) *	1991-03-22	1991-05-08	Sandoz Ltd	Improvements in or relating to organic compounds
JPH08291140A (ja) *	1995-04-20	1996-11-05	Teikoku Chem Ind Corp Ltd	易吸収性結晶
HRP20010123B1 (hr) *	1998-08-21	2010-11-30	Novartis Aktiengesellschaft	Nova oralna formulacija za 5-ht<sub>4</sub> agoniste ili antagoniste
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod
CN1176077C (zh) *	2003-01-07	2004-11-17	江苏省药物研究所	马来酸替加色罗一水结晶
US20050119328A1 (en) *	2003-03-25	2005-06-02	Hetero Drugs Limited	Novel crysalline forms of tegaserod maleate
US20050165085A1 (en) *	2003-12-16	2005-07-28	Marioara Mendelovici	Polymorphic forms of tegaserod base and salts thereof
US20050272802A1 (en) *	2004-04-22	2005-12-08	Sundaram Venkataraman	Process for preparing form I of tegaserod maleate
MX2007002113A (es) *	2005-06-22	2007-04-27	Teva Pharma	Formas polimorfas de maleato de tegaserod.

2004
- 2004-07-22 PE PE2004000706A patent/PE20050253A1/es not_active Application Discontinuation
- 2004-07-22 AR ARP040102610A patent/AR045081A1/es not_active Application Discontinuation
- 2004-07-22 MY MYPI20042945A patent/MY137386A/en unknown
- 2004-07-22 TW TW093121920A patent/TW200510302A/zh unknown
- 2004-07-23 EP EP04763452A patent/EP1651601A1/en not_active Withdrawn
- 2004-07-23 CN CNA2004800213549A patent/CN1826318A/zh active Pending
- 2004-07-23 KR KR1020067001500A patent/KR20060040710A/ko not_active Ceased
- 2004-07-23 NZ NZ544596A patent/NZ544596A/en unknown
- 2004-07-23 SG SG200805476-9A patent/SG144944A1/en unknown
- 2004-07-23 BR BRPI0412830-3A patent/BRPI0412830A/pt not_active IP Right Cessation
- 2004-07-23 CA CA002532351A patent/CA2532351A1/en not_active Abandoned
- 2004-07-23 EP EP07117155A patent/EP1880992A1/en not_active Withdrawn
- 2004-07-23 JP JP2006520806A patent/JP2006528609A/ja active Pending
- 2004-07-23 MX MXPA06000917A patent/MXPA06000917A/es unknown
- 2004-07-23 WO PCT/EP2004/008281 patent/WO2005014544A1/en not_active Ceased
- 2004-07-23 AU AU2004263285A patent/AU2004263285A1/en not_active Abandoned
- 2004-07-23 RU RU2006105481/04A patent/RU2349585C2/ru not_active IP Right Cessation
- 2004-07-23 US US10/565,454 patent/US20070112056A1/en not_active Abandoned
2005
- 2005-12-29 IL IL172914A patent/IL172914A0/en unknown
2006
- 2006-01-23 TN TNP2006000024A patent/TNSN06024A1/en unknown
- 2006-01-24 EC EC2006006306A patent/ECSP066306A/es unknown
- 2006-01-27 MA MA28759A patent/MA27935A1/fr unknown
- 2006-02-21 CO CO06016978A patent/CO5680418A2/es not_active Application Discontinuation
- 2006-02-22 IS IS8321A patent/IS8321A/is unknown
- 2006-02-24 NO NO20060915A patent/NO20060915L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20070112056A1 (en)	2007-05-17
NZ544596A (en)	2009-01-31
CN1826318A (zh)	2006-08-30
MXPA06000917A (es)	2006-03-30
MY137386A (en)	2009-01-30
WO2005014544A1 (en)	2005-02-17
ECSP066306A (es)	2006-07-28
PE20050253A1 (es)	2005-06-03
JP2006528609A (ja)	2006-12-21
CA2532351A1 (en)	2005-02-17
BRPI0412830A (pt)	2006-09-26
NO20060915L (no)	2006-04-24
AU2004263285A1 (en)	2005-02-17
RU2006105481A (ru)	2007-09-20
IL172914A0 (en)	2006-06-11
IS8321A (is)	2006-02-22
EP1651601A1 (en)	2006-05-03
KR20060040710A (ko)	2006-05-10
CO5680418A2 (es)	2006-09-29
TNSN06024A1 (en)	2007-10-03
RU2349585C2 (ru)	2009-03-20
MA27935A1 (fr)	2006-06-01
AR045081A1 (es)	2005-10-12
TW200510302A (en)	2005-03-16
EP1880992A1 (en)	2008-01-23

Publication	Publication Date	Title
EP1486587A4 (en)	2005-06-01	ELECTRODE FOR THE PRODUCTION OF HYDROGEN
EP1765745A4 (en)	2009-06-03	DISSOCIATION OF MOLECULAR WATER TO MOLECULAR HYDROGEN
AU2003286894A8 (en)	2004-06-07	Hydrogen generator
GB2409865B (en)	2008-05-28	Commercial production of hydrogen from water
PL1615622T3 (pl)	2012-12-31	Preparaty doksycyklin do jednorazowego dziennego podawania
IL173440A0 (en)	2006-06-11	Novel formulation of ropinirole
IL182334A0 (en)	2007-07-24	Synthesis of hydrogen peroxide
IL172914A0 (en)	2006-06-11	Stable modifications of tegaserod hydrogen maleate
GB0326768D0 (en)	2003-12-24	Generation of therapeutic microfoam
AU2003269638A8 (en)	2004-04-19	Hydrogen generator
AU2003222439A1 (en)	2004-10-18	Novel crystalline forms of tegaserod maleate
IL176424A0 (en)	2006-10-05	Preparation of tegaserod and tegaserod maleate
AU2003229987A8 (en)	2003-11-17	Hydrogen generation
HK1090040A (en)	2006-12-15	Stable modifications of tegaserod hydrogen maleate
TW562258U (en)	2003-11-11	Structure of 3D inverted F-antenna
GB0217801D0 (en)	2002-09-11	Hydrogen
TW569704U (en)	2004-01-01	Improved structure of dual-liquid-type container
TW533806U (en)	2003-05-21	Structure of improved-type chair
GB0320513D0 (en)	2003-10-01	Production of hydrogen
TW558985U (en)	2003-10-21	Improved structure of hammock
TW578496U (en)	2004-03-01	Improved structure of assembled closet
GB0324738D0 (en)	2003-11-26	Personal deodorant of natural origin
TW551680U (en)	2003-09-01	Improved structure of telecommunication connection socket
TW557716U (en)	2003-10-11	Structure of mouth set for water pitcher
TW579775U (en)	2004-03-11	Improved structure of chair